Cargando…
Immune checkpoint blockade opens an avenue of cancer immunotherapy with a potent clinical efficacy
Recent progress in tumor immunology has revealed that tumors generate immunologically restrained milieu during the process of their growth, which facilitates the escape of tumors from host immune systems. Immune checkpoint molecules, which transduce co-inhibitory signals to immuno-competent cells, a...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Ltd
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556381/ https://www.ncbi.nlm.nih.gov/pubmed/25981182 http://dx.doi.org/10.1111/cas.12695 |